| Literature DB >> 31415180 |
Magdalene K Montgomery1,2, Brenna Osborne1, Amanda E Brandon3,4, Liam O'Reilly3, Corrine E Fiveash1, Simon H J Brown5,6, Brendan P Wilkins1,7, Azrah Samsudeen1, Josephine Yu1, Beena Devanapalli8, Ashley Hertzog8, Adviye A Tolun8,9,10, Tomas Kavanagh11, Antony A Cooper11,12, Todd W Mitchell6,13, Trevor J Biden3,12, Nicola J Smith7,12, Gregory J Cooney3,4, Nigel Turner1.
Abstract
Fatty acid receptors have been recognized as important players in glycaemic control. This study is the first to describe a role for the medium-chain fatty acid (MCFA) receptor G-protein-coupled receptor (Gpr) 84 in skeletal muscle mitochondrial function and insulin secretion. We are able to show that Gpr84 is highly expressed in skeletal muscle and adipose tissue. Mice with global deletion of Gpr84 [Gpr84 knockout (KO)] exhibit a mild impairment in glucose tolerance when fed a MCFA-enriched diet. Studies in mice and pancreatic islets suggest that glucose intolerance is accompanied by a defect in insulin secretion. MCFA-fed KO mice also exhibit a significant impairment in the intrinsic respiratory capacity of their skeletal muscle mitochondria, but at the same time also exhibit a substantial increase in mitochondrial content. Changes in canonical pathways of mitochondrial biogenesis and turnover are unable to explain these mitochondrial differences. Our results show that Gpr84 plays a crucial role in regulating mitochondrial function and quality control.-Montgomery, M. K., Osborne, B., Brandon, A. E., O'Reilly, L., Fiveash, C. E., Brown, S. H. J., Wilkins, B. P., Samsudeen, A., Yu, J., Devanapalli, B., Hertzog, A., Tolun, A. A., Kavanagh, T., Cooper, A. A., Mitchell, T. W., Biden, T. J., Smith, N. J., Cooney, G. J., Turner, N. Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84.Entities:
Keywords: insulin resistance; insulin secretion; mitochondrial function
Mesh:
Substances:
Year: 2019 PMID: 31415180 PMCID: PMC9292139 DOI: 10.1096/fj.201900234R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.834